Literature DB >> 3633772

The contact activation system: biochemistry and interactions of these surface-mediated defense reactions.

R W Colman, A H Schmaier.   

Abstract

This review is intended to be a critical state-of-the-art overview of the activation and inhibition of the proteins (factor XII, prekallikrein, high molecular weight kininogen, and factor XI) of the contact phase of coagulation. Specifically, this review will reconsider the concept of the reciprocal activation of the proteases of the contact phase of coagulation, factor XII, and prekallikrein, in light of much recent evidence indicating that factor XII, itself, autoactivates when associated with negatively charged surfaces. In addition, the mechanisms for amplification of activation of the proteins of the contact phase of coagulation will be discussed from the pivotal role of high molecular weight kininogen, or one of its altered forms, serving as a cofactor to order the activation of the zymogens it is associated with. The role and relative importance of each of the naturally occurring plasma protease inhibitors (C1-inhibitor, alpha-2-macroglobulin, alpha-1-antitrypsin, antithrombin III, and alpha-1-antiplasmin) will be assessed as they relate to the dampening of contact phase activation. Finally, the contact phase of coagulation activation will be discussed not only as a plasma proteolytic mechanism, but also as it interacts with platelets.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3633772     DOI: 10.1016/s1040-8428(86)80053-1

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  8 in total

1.  Tracks of a non-main path traveler: 2011 Thomas Willis Lecture.

Authors:  John M Hallenbeck
Journal:  Stroke       Date:  2012-01-12       Impact factor: 7.914

2.  Transforming growth factor-β1 induces expression of human coagulation factor XII via Smad3 and JNK signaling pathways in human lung fibroblasts.

Authors:  Ewa Jablonska; Philipp Markart; Dariusz Zakrzewicz; Klaus T Preissner; Malgorzata Wygrecka
Journal:  J Biol Chem       Date:  2010-02-08       Impact factor: 5.157

3.  An analysis of the contact phase of blood coagulation: effects of shear rate and surface are intertwined.

Authors:  K Gregory; D Basmadjian
Journal:  Ann Biomed Eng       Date:  1994 Mar-Apr       Impact factor: 3.934

Review 4.  Single-chain factor XII: a new form of activated factor XII.

Authors:  Ivan Ivanov; Anton Matafonov; David Gailani
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

5.  Monitoring of immunotherapy with cytokines or monoclonal antibodies.

Authors:  C Erik Hack
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

Review 6.  C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.

Authors:  C E Hack; A C Ogilvie; B Eisele; A J Eerenberg; J Wagstaff; L G Thijs
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  The interaction of factor VIIa with rehydrated, lyophilized platelets.

Authors:  Thomas H Fischer; Alisa S Wolberg; Arthur P Bode; Timothy C Nichols
Journal:  Platelets       Date:  2008-05       Impact factor: 3.862

Review 8.  Human plasma kallikrein-kinin system: physiological and biochemical parameters.

Authors:  J W Bryant; Z Shariat-Madar
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.